Tanzania AIDS Malignancies Training and Research Program (TAMTRP)

坦桑尼亚艾滋病恶性肿瘤培训和研究计划 (TAMTRP)

基本信息

  • 批准号:
    10601111
  • 负责人:
  • 金额:
    $ 29.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2027-01-31
  • 项目状态:
    未结题

项目摘要

Abstract The overall objective of the proposed Tanzania AIDS Malignancies Training and Research Program (TAMTRP) is to enhance the cancer research capacity of the major cancer research institution in Tanzania, the Ocean Road Cancer Institute (ORCI) in partnership with the Stanley S. Scott Cancer Center (SSSCC) at the Louisiana State University Health Science Center in New Orleans (LSUHSC-NO). The proposed program will build onto our existing collaboration, prepare ORCI personnel to fill gaps in expertise while preparing for the future of HIV associated cancer diagnostics and research in cancer genomics and therapy. The scientific focus of TAMTRP is research and training in molecular detection/diagnosis, and in quantifying the epidemiology and biology of the most common HIV associated malignancies in Tanzania, especially those with infectious etiology. The short-term goals are: 1) to enhance the ORCI cancer research and training infrastructure. 2) Institute a training and mentoring program for Tanzanians to conduct research on cancers that are commonly encountered at ORCI and SSSCC. These goals will be accomplished through three specific aims: 1) Provide intensive academic instruction and research experience for two PhD and four Master's degree candidates in a relevant HIV associated cancer research field. 2) Provide medium-term (three to six months) technical training opportunities for post-graduates and health care providers in topics related to molecular pathology, cancer biology, bioinformatics, genomics, biostatistics, bio banking, cancer registry, as well as clinical and translational research. 3) Deliver technical workshops designed to enhance basic, clinical, implementation, genomics, bioinformatics, computation genomics, epidemiology, biostatistics, and continue to expand collaborations between partner institutions to enhance the research capability and infrastructure in Tanzania. There are four training tracks: a) clinical trials methodologies and management; b) public health operational and translational research– including cancer prevention, biostatistics and data management, epidemiology, cancer registry, and bio banking; c) laboratory-based cancer biology research– including molecular biology/virology, pathology, diagnostics, viral oncology, and immunology; d) cancer genomics and bioinformatics–including next generation sequencing, data management, big data analytics, and computational genomics. TAMTRP will be critical in the preparation of ORCI (and Tanzania) for the era of personalized and precision cancer medicine, which will utilize cancer genomics for cancer detection, diagnosis, prevention, and treatment. It will provide important insight in the understanding and prevention of HIV associated and non-HIV associated malignancies in Tanzania, and reciprocally, in the U.S.
抽象的 拟议的坦桑尼亚AIDS MALIGHANCYS培训与研究计划(TAMTRP)的总体目标 是为了增强坦桑尼亚主要癌症研究机构的癌症研究能力 路易斯安那州的Stanley S. Scott癌症中心(SSSCC)合作,路癌研究所(ORCI) 新奥尔良州立大学健康科学中心(LSUHSC-NO)。提议的程序将建立 我们现有的合作,准备ORCI人员以填补专业知识的空白,同时为艾滋病毒的未来做准备 相关的癌症诊断和癌症基因组学和治疗研究。 Tamtrp的科学重点 是分子检测/诊断的研究和培训,以及量化的流行病学和生物学 坦桑尼亚最常见的艾滋病毒相关的艾滋病毒恶性肿瘤,尤其是患有感染性病因的恶性肿瘤。这 短期目标是:1)增强ORCI癌症研究和培训基础设施。 2)研究所 坦桑尼亚人对癌症进行研究的培训和心理计划 在Orci和SSSCC遇到。这些目标将通过三个具体目标来实现:1)提供 两种博士学位和四个硕士学位候选人的密集学业教学和研究经验 相关艾滋病毒相关的癌症研究领域。 2)提供中期(三到六个月)的技术培训 在与分子病理学有关的主题中的后研究生和医疗保健提供者的机会 生物学,生物信息学,基因组学,生物统计学,生物群,癌症注册表以及临床和转化 研究。 3)提供旨在增强基本,临床,实施,基因组学的技术研讨会 生物信息学,计算基因组学,流行病学,生物统计学,并继续扩大合作 在合作伙伴机构之间增强坦桑尼亚的研究能力和基础设施。有四个 培训轨道:a)临床试验方法和管理; b)公共卫生运营和翻译 研究 - 包括预防癌症,生物统计学和数据管理,流行病学,癌症注册表和 生物银行; c)基于实验室的癌症生物学研究 - 包括分子生物学/病毒学,病理学, 诊断,病毒肿瘤学和免疫学; D)癌症基因组学和生物信息学 - 包括下一代 测序,数据管理,大数据分析和计算基因组学。 tamtrp在 为个性化和精确的癌症医学时代准备Orci(和坦桑尼亚),这将 利用癌症基因组学进行癌症检测,诊断,预防和治疗。它将提供重要的 洞悉与艾滋病毒相关和非HIV相关的恶性肿瘤的理解和预防 坦桑尼亚和相互的美国

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Julius David Mwais...的其他基金

Kaposi Sarcoma in the Era of ART in Africa Program (KEAAP)
非洲抗逆转录病毒治疗时代的卡波西肉瘤计划 (KEAAP)
  • 批准号:
    10598769
    10598769
  • 财政年份:
    2023
  • 资助金额:
    $ 29.13万
    $ 29.13万
  • 项目类别:
Tanzania AIDS Malignancies Training and Research International Program (TAMTRP)
坦桑尼亚艾滋病恶性肿瘤培训和研究国际计划 (TAMTRP)
  • 批准号:
    10650673
    10650673
  • 财政年份:
    2022
  • 资助金额:
    $ 29.13万
    $ 29.13万
  • 项目类别:
Tanzania AIDS Malignancies Training and Research Program (TAMTRP)
坦桑尼亚艾滋病恶性肿瘤培训和研究计划 (TAMTRP)
  • 批准号:
    10472142
    10472142
  • 财政年份:
    2022
  • 资助金额:
    $ 29.13万
    $ 29.13万
  • 项目类别:

相似海外基金

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV
AVANÇO 研究联盟:莫桑比克/巴西/德克萨斯州联盟,旨在推进新颖且负担得起的技术,用于预防和诊断艾滋病毒感染妇女的宫颈癌
  • 批准号:
    10598934
    10598934
  • 财政年份:
    2023
  • 资助金额:
    $ 29.13万
    $ 29.13万
  • 项目类别:
Botswana CASCADE Clinical Trials Site
博茨瓦纳 CASCADE 临床试验现场
  • 批准号:
    10544424
    10544424
  • 财政年份:
    2022
  • 资助金额:
    $ 29.13万
    $ 29.13万
  • 项目类别:
Tanzania AIDS Malignancies Training and Research Program (TAMTRP)
坦桑尼亚艾滋病恶性肿瘤培训和研究计划 (TAMTRP)
  • 批准号:
    10472142
    10472142
  • 财政年份:
    2022
  • 资助金额:
    $ 29.13万
    $ 29.13万
  • 项目类别:
Translational Core
翻译核心
  • 批准号:
    10084050
    10084050
  • 财政年份:
    2020
  • 资助金额:
    $ 29.13万
    $ 29.13万
  • 项目类别:
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies
爱因斯坦/卢旺达/刚果民主共和国艾滋病毒/HPV/恶性肿瘤研究联盟
  • 批准号:
    10267218
    10267218
  • 财政年份:
    2020
  • 资助金额:
    $ 29.13万
    $ 29.13万
  • 项目类别: